Fadi Alkhatib, DO
Allergy & Immunology · West Des Moines, IANPI 1972869717
Payments from drug & device makers
Across 470 payments — averaging $33.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$6K
- AstraZeneca$3K
- GSK$1K
- Sanofi$815
- Amgen$813
- Regeneron Healthcare Solutions, Inc.$416
- plus $3K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 46 | $6,332 |
| AstraZeneca | 99 | $2,958 |
| GSK | 74 | $1,097 |
| Sanofi | 53 | $815 |
| Amgen(2 entities) | 38 | $813 |
| Regeneron Healthcare Solutions, Inc. | 20 | $416 |
| Galderma Laboratories, L.p. | 16 | $410 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $353 |
| Pharming Healthcare, Inc. | 13 | $310 |
| Boehringer Ingelheim | 8 | $283 |
| Pfizer | 13 | $238 |
| CSL Behring | 9 | $191 |
| Biocryst US Sales Co., LLC | 10 | $188 |
| Alk-abello, Inc | 8 | $148 |
| Sanofi-aventis U.S. LLC | 2 | $121 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $117 |
| Novartis | 7 | $117 |
| Optinose US, Inc. | 5 | $96 |
| Grifols USA, LLC | 4 | $68 |
| Blueprint Medicines Corporation | 3 | $66 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| Kaleo, Inc. | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Incyte Corporation | 2 | $43 |
| Phadia US Inc. | 2 | $42 |
| Ionis Pharmaceuticals, Inc. | 2 | $40 |
| Mylan Specialty L.p. | 2 | $27 |
| Tactile Systems Technology Inc | 1 | $19 |
| LEO Pharma Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $17 |
| Covis Pharma GmbH | 1 | $16 |
| Verona Pharma, Inc. | 1 | $14 |
| Organon | 1 | $13 |
| USWM, LLC | 1 | $13 |
| Circassia Inc. | 1 | $11 |
How this compares
$15,564 in reported general payments places this provider in the 75th percentile of 32 allergy & immunology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in West Des Moines
- Jennifer PettsWest Des Moines$631K
- Vuong NayimaWest Des Moines$34K
- Ravinder AgarwalWest Des Moines$2K
- Ahmad AlshashWest Des Moines$872
- Jay BrownAmes$669K
- Daniel HamilosMason City$121K
- Benjamin DavisIowa City$109K
- Jason CascioAmes$38K
- Zuhair BallasIowa City$35K
- Lyla SchweigerCedar Rapids$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.